|
US4559157A
(en)
|
1983-04-21 |
1985-12-17 |
Creative Products Resource Associates, Ltd. |
Cosmetic applicator useful for skin moisturizing
|
|
LU84979A1
(fr)
|
1983-08-30 |
1985-04-24 |
Oreal |
Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
|
|
US4820508A
(en)
|
1987-06-23 |
1989-04-11 |
Neutrogena Corporation |
Skin protective composition
|
|
US4992478A
(en)
|
1988-04-04 |
1991-02-12 |
Warner-Lambert Company |
Antiinflammatory skin moisturizing composition and method of preparing same
|
|
US4938949A
(en)
|
1988-09-12 |
1990-07-03 |
University Of New York |
Treatment of damaged bone marrow and dosage units therefor
|
|
US5723459A
(en)
|
1991-05-09 |
1998-03-03 |
Vertex Pharmaceuticals Incorporated |
Biologically active acylated amino acid derivatives
|
|
US5844001A
(en)
|
1993-02-26 |
1998-12-01 |
Research Development Foundation |
Combination platinum chemotherapeutic/antiestrogen therapy for human cancers
|
|
FR2757866B1
(fr)
|
1996-12-30 |
2004-12-17 |
Catalyse |
Polymeres comportant des groupes ammoniums quaternaires, leur utilisation pour la fabrication d'un materiau a propretes antibacteriennes et leurs procedes de preparation
|
|
US6403765B1
(en)
|
1998-06-16 |
2002-06-11 |
Thomas Jefferson University |
Truncated Apaf-1 and methods of use thereof
|
|
EP1100932A2
(en)
|
1998-07-27 |
2001-05-23 |
PHARMACIA & UPJOHN COMPANY |
Method for autoactivation of procaspase 8
|
|
US6110691A
(en)
|
2000-01-06 |
2000-08-29 |
Board Of Regents, The University Of Texas System |
Activators of caspases
|
|
US6608026B1
(en)
|
2000-08-23 |
2003-08-19 |
Board Of Regents, The University Of Texas System |
Apoptotic compounds
|
|
WO2002030399A2
(en)
|
2000-10-11 |
2002-04-18 |
Johns Hopkins University |
Polymer controlled delivery of a therapeutic agent
|
|
WO2002048329A2
(en)
|
2000-11-20 |
2002-06-20 |
Idun Pharmaceuticals, Inc. |
Membrane derived caspase-3, compositions comprising the same and methods of use therefor
|
|
WO2003024955A2
(en)
|
2001-09-18 |
2003-03-27 |
Sunesis Pharmaceuticals, Inc. |
Small molecule inhibitors of caspases
|
|
WO2004066958A2
(en)
|
2003-01-30 |
2004-08-12 |
The Trustees Of Princeton University |
Caspase-9:bir3 domain of xiap complexes and methods of use
|
|
US7632972B2
(en)
|
2003-10-30 |
2009-12-15 |
The Board Of Trustees Of The University Of Illionis |
Compounds and methods for treatment of cancer and modulation of programmed cell death for melanoma and other cancer cells
|
|
ATE447957T1
(de)
|
2003-12-09 |
2009-11-15 |
Us Gov Health & Human Serv |
Verfahren zur unterdrückung einer immunantwort oder zur behandlung von proliferativen erkrankungen
|
|
US8440610B2
(en)
|
2004-11-12 |
2013-05-14 |
Massachusetts Institute Of Technology |
Mapkap kinase-2 as a specific target for blocking proliferation of P53-defective cells
|
|
US20070049602A1
(en)
|
2005-05-26 |
2007-03-01 |
The Board Of Trustees Of The University Of Illinois |
Selective Apoptotic Induction in Cancer Cells Including Activation of Procaspase-3
|
|
WO2008134474A2
(en)
|
2007-04-27 |
2008-11-06 |
The Board Of Trustees Of The University Of Illinois |
Compositions and methods including cell death inducers and procaspase activation
|
|
CN101184491A
(zh)
|
2005-05-26 |
2008-05-21 |
伊利诺伊大学评议会 |
包括活化半胱天冬酶-3酶原的癌细胞内选择性细胞凋亡诱导
|
|
WO2007002254A2
(en)
|
2005-06-23 |
2007-01-04 |
Merck & Co., Inc. |
Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met
|
|
US7470787B2
(en)
|
2005-07-11 |
2008-12-30 |
Aerie Pharmaceuticals, Inc. |
Isoquinoline compounds
|
|
TWI373473B
(en)
|
2005-09-02 |
2012-10-01 |
Otsuka Pharma Co Ltd |
Anticancer agent
|
|
CA2622867A1
(en)
|
2005-09-16 |
2007-03-22 |
Schering Corporation |
Pharmaceutical compositions and methods using temozolomide and a protein kinase inhibitor
|
|
US20070111936A1
(en)
|
2005-11-15 |
2007-05-17 |
Vladimir Pak |
Complex of alpha-fetoprotein and inducers of apoptosis for the treatment of cancer
|
|
JP2009537636A
(ja)
|
2006-05-19 |
2009-10-29 |
ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティー オブ イリノイ |
黒色腫及び他の癌を治療するためのトリフェニルメチルホスホン酸エステルを含めたリン含有化合物
|
|
TWI433674B
(zh)
|
2006-12-28 |
2014-04-11 |
Infinity Discovery Inc |
環杷明（ｃｙｃｌｏｐａｍｉｎｅ）類似物類
|
|
PT2176231T
(pt)
|
2007-07-20 |
2016-12-09 |
Nerviano Medical Sciences Srl |
Derivados de indazol substituídos activos como inibidores de quinases
|
|
RU2360692C1
(ru)
|
2007-12-21 |
2009-07-10 |
Тихоокеанский Институт Биоорганической Химии Дальневосточного Отделения Российской Академии Наук (Тибох Дво Ран) |
Средство, стимулирующее апоптоз клеток лейкемии человека
|
|
MX2010007548A
(es)
|
2008-01-11 |
2010-11-25 |
Univ California |
Activadores de procaspasas 3, 6 y 7 efectoras.
|
|
US20100291214A1
(en)
|
2008-12-23 |
2010-11-18 |
Armark Authentication Technologies, Llc |
Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure
|
|
AU2010210404A1
(en)
|
2009-02-09 |
2011-08-25 |
St. Jude Medical, Cardiology Division, Inc. |
Inflatable minimally invasive system for delivering and securing an annular implant
|
|
US8778945B2
(en)
|
2009-02-09 |
2014-07-15 |
The Board Of Trustees Of The University Of Illinois |
Design, synthesis and evaluation of procaspase activating compounds as personalized anti-cancer drugs
|
|
CN102481271A
(zh)
|
2009-05-11 |
2012-05-30 |
博格生物系统有限责任公司 |
利用表观代谢转变剂、多维细胞内分子或环境影响剂治疗代谢障碍的方法
|
|
CA2763471A1
(en)
|
2009-05-27 |
2010-12-02 |
Cephalon, Inc. |
Combination therapy for the treatment of multiple myeloma
|
|
WO2010151746A2
(en)
|
2009-06-26 |
2010-12-29 |
Armark Authentication Technologies, Llc |
Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure
|
|
TWI386203B
(zh)
|
2011-01-07 |
2013-02-21 |
Univ China Medical |
治療腦癌或用以降低腦癌細胞對替莫唑胺之抗藥性之醫藥組合物及其應用
|
|
WO2012118978A1
(en)
|
2011-03-03 |
2012-09-07 |
The Regents Of The University Of Colorado, A Body Corporate |
Methods for treating oncovirus positive cancers
|
|
WO2012178038A1
(en)
|
2011-06-24 |
2012-12-27 |
The Broad Institute, Inc. |
Methods of treating cancer
|
|
EP4119551A1
(en)
*
|
2011-07-27 |
2023-01-18 |
Astrazeneca AB |
2-(2,4,5-substituted-anilino)pyrimidine compounds
|
|
US8916705B2
(en)
|
2011-10-14 |
2014-12-23 |
The Board of Trustees of The University of Illilnois |
Procaspase-activating compounds and compositions
|
|
AU2013225682B2
(en)
|
2012-03-02 |
2016-04-14 |
The Board Of Trustees Of The University Of Illinois |
Potent anticancer activity via dual compound activation
|
|
AU2013230985B2
(en)
|
2012-03-06 |
2016-05-12 |
The Board Of Trustees Of The University Of Illinois |
Procaspase combination therapy for glioblastoma
|
|
CA2866021C
(en)
*
|
2012-03-06 |
2020-09-22 |
The Board Of Trustees Of The University Of Illinois |
Procaspace 3 activation by pac-1 combination therapy
|
|
US9249116B2
(en)
|
2012-08-03 |
2016-02-02 |
The Board Of Trustees Of The University Of Illinois |
Enzyme-activating compounds and compositions
|
|
EP2917348A1
(en)
|
2012-11-06 |
2015-09-16 |
InteRNA Technologies B.V. |
Combination for use in treating diseases or conditions associated with melanoma, or treating diseases or conditions associated with activated b-raf pathway
|
|
CN105163584B
(zh)
|
2013-03-05 |
2019-06-04 |
田纳西大学研究基金会 |
用于治疗癌症的化合物
|
|
ES2822665T3
(es)
|
2013-05-31 |
2021-05-04 |
Merck Sharp & Dohme |
Terapias de combinación para el cáncer
|
|
CN111053768B
(zh)
|
2013-07-12 |
2023-12-12 |
皮拉马尔企业有限公司 |
用于治疗黑素瘤的药物组合
|
|
GB201320302D0
(en)
*
|
2013-11-18 |
2014-01-01 |
Element Six Ltd |
Diamond components for quantum imaging sensing and information processing devices
|
|
IL256111B2
(en)
|
2015-06-05 |
2023-09-01 |
Univ Illinois |
Treatment of pac combinations
|
|
AU2016370846B2
(en)
|
2015-12-18 |
2022-08-25 |
Ignyta, Inc. |
Combinations for the treatment of cancer
|
|
EP3548049A4
(en)
|
2016-12-05 |
2020-07-22 |
Fate Therapeutics, Inc. |
COMPOSITIONS AND METHODS FOR MODULATION OF IMMUNE CELLS IN ADOPTIVE IMMUNOTHERAPIES
|
|
JOP20190213A1
(ar)
|
2017-03-16 |
2019-09-16 |
Array Biopharma Inc |
مركبات حلقية ضخمة كمثبطات لكيناز ros1
|
|
AU2018368453B2
(en)
*
|
2017-11-17 |
2024-05-30 |
The Board Of Trustees Of The University Of Illinois |
Cancer therapy by degrading dual MEK signaling
|